Commodore Capital’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Sell |
2,311,164
-6,581,652
| -74% | -$47.3M | 1.17% | 23 |
|
|
2025
Q1 | $53.3M | Buy |
8,892,816
+2,011,187
| +29% | +$12M | 3.93% | 12 |
|
|
2024
Q4 | $53.7M | Sell |
6,881,629
-658,301
| -9% | -$5.13M | 3.93% | 10 |
|
|
2024
Q3 | $81.4M | Sell |
7,539,930
-2,198,070
| -23% | -$23.7M | 5.09% | 7 |
|
|
2024
Q2 | $82.1M | Buy |
9,738,000
+3,313,000
| +52% | +$27.9M | 5.6% | 7 |
|
|
2024
Q1 | $43.2M | Buy |
6,425,000
+858,974
| +15% | +$5.77M | 2.89% | 12 |
|
|
2023
Q4 | $32.7M | Hold |
5,566,026
| – | – | 2.86% | 13 |
|
|
2023
Q3 | $54.3M | Hold |
5,566,026
| – | – | 6.34% | 5 |
|
|
2023
Q2 | $65.9M | Buy |
5,566,026
+793,605
| +17% | +$9.4M | 7.41% | 5 |
|
|
2023
Q1 | $51.5M | Buy |
4,772,421
+452,481
| +10% | +$4.88M | 7.84% | 4 |
|
|
2022
Q4 | $49.9M | Hold |
4,319,940
| – | – | 7.53% | 3 |
|
|
2022
Q3 | $64.5M | Sell |
4,319,940
-624,768
| -13% | -$9.32M | 10.36% | 1 |
|
|
2022
Q2 | $44.6M | Buy |
4,944,708
+1,443,940
| +41% | +$13M | 9.43% | 3 |
|
|
2022
Q1 | $26.2M | Buy |
3,500,768
+1,219,453
| +53% | +$9.13M | 5.86% | 8 |
|
|
2021
Q4 | $19.6M | Buy |
2,281,315
+368,804
| +19% | +$3.16M | 4.53% | 8 |
|
|
2021
Q3 | $16.1M | Buy |
1,912,511
+544,929
| +40% | +$4.58M | 4.24% | 8 |
|
|
2021
Q2 | $11.1M | Buy |
1,367,582
+98,387
| +8% | +$798K | 3.86% | 9 |
|
|
2021
Q1 | $11.1M | Buy |
1,269,195
+509,170
| +67% | +$4.47M | 4.44% | 7 |
|
|
2020
Q4 | $8.54M | Buy |
+760,025
| New | +$8.54M | 4.64% | 8 |
|